Chemours Co

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $3.27B
  • PE 48
  • Debt $4.13B
  • Cash $666.00M
  • EV $6.73B
  • FCF -$673.00M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$68.00M
EBIT$37.00M
ROE10%
ROA0%
FCF-$673.00M
Equity$659.00M
Growth Stability-51%
PE48.06
PEG-7.09
PB4.96
P/FCF-4.86
P/S0.57
Price/Cash0.2
Debt/Equity6.27
Debt/FCF-6.14
Net Margins2%
Gross Margins20%
Op. Margins1%
Earnings CAGR1%
Sales Growth YoY1%
Sales Growth QoQ-2%
Sales CAGR1%
FCF CAGR-3%
Equity CAGR9%
Earnings Stability0
Earnings Growth YoY-242%
Earnings Growth QoQ-139%
Earnings CAGR 5Y-7%
Sales CAGR 5Y4%
FCF CAGR 5Y-19%
Equity CAGR 5Y1%
Earnings CAGR 3Y-7%
Sales CAGR 3Y-7%
FCF CAGR 3Y-41%
Equity CAGR 3Y-22%
Market Cap$3.27B
Revenue$5.75B
Dividend Yield5%
Payout Ratio219%
Assets$7.46B
Total Debt$4.13B
Cash$666.00M
Shares Outstanding149.38M
EV6.73B
Earnings Score6%
Moat Score55%
Safety Score21%
Final Score28%
Working Capital1.3B
Current Ratio1.73
Gross Profit$1.13B
Shares Growth 3y-2%
Equity Growth QoQ-9%
Equity Growth YoY-13%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets. The company's operating segments include Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment, a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications. Geographically, it derives a majority of revenue from North America.

SEC Filings

Direct access to Chemours Co (CC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Chemours Co compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Chemours Co compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 1%
Stability 0%
loading chart...

Chemours Co Discounted Cash Flow

Fully customizable DCF calculator online for Chemours Co.

= -$5.6B
012345678910TV
fcf-$673M-$654M-$636M-$618M-$601M-$585M-$568M-$553M-$537M-$522M-$508M-$5.1B
DCF-$595M-$526M-$465M-$411M-$363M-$321M-$284M-$251M-$222M-$196M-$2B
Value-$5.6B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins6%-2%0%12%15%-1%4%10%9%-4%2%
ROA--3%-0%13%16%-2%3%9%10%-4%0%
ROE--69%7%86%98%-7%27%56%52%-32%10%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF--12.0314.0918.326.2825.627.567.018.222.23-6.14
Debt over Equity031.1834.674.833.956.235.013.523.315.66.27
Growth Stability---100%100%-9%39%100%100%-51%-51%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth--11%-6%15%7%-17%-10%28%7%-11%4%
Earnings YoY growth--123%-108%11K%33%-105%-521%178%-5%-141%-7%
Equity YoY growth--96%-20%732%18%-32%17%33%2%-33%1%
FCF YoY growth-240%-176%-11%182%-74%220%1%-18%-58%-19%